#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Henoch-Schonlein purpura Kidney transplant rejection Acute respiratory distress syndrome Leukocyte adhesion deficiency Synovial sarcoma Li-Fraumeni syndrome Factor VIII deficiency Dent's disease Thromboangiitis obliterans Indolent systemic mastocytosis Amyotrophic lateral sclerosis Polyneuropathy Breast angiosarcoma Bronchopulmonary aspergillosis Marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Basic Information Mitochondrial myopathy Glomerulonephritis membranoproliferative – Life with Disease Glycogen storage disease type II Synovial sarcoma recurrent – Life with Disease Cystic fibrosis lung – Life with Disease Focal segmental glomerulosclerosis – Basic Information Mantle cell lymphoma stage II – Diagnostics Sjogren’s syndrome – Life with Disease Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fosamprenavir Calcium Interferon Beta-1A Bms-986315 Clopidogrel Hydrogen Sulfate Keto-Valine Calcium Sodium Alginate Mva-209-Fsp-B3 LVT-001 Ziltivekimab Carbetocin INF904 Keto-Leucine Calcium Keto-Isoleucine Calcium ANTI-GD2-800CW ADX-324 Montelukast GXV813 Aspergillus Fumigatus Vonicog Alfa Elotuzumab More therapies…

    Learn about Your Condition

    Ectopic pregnancy Oropharyngeal cancer Fragile X syndrome Breast angiosarcoma Pyrexia Pancreatitis acute Myeloid leukaemia Biopsy heart Pelizaeus-Merzbacher disease Gender dysphoria Mucopolysaccharidosis Lung transplant rejection Alopecia areata Genitourinary tract neoplasm Thromboembolectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteoporosis

  • Study on Zoledronic Acid for Healing After Rotator Cuff Surgery in Patients with Tendon Rupture and Osteoporosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Tendon injury
    Investigated Drugs:
    • Zoledronic Acid
    Austria

  • Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Alendronic Acid
    • Tetracycline Hydrochloride
    Denmark

  • Study on Zoledronic Acid Following Denosumab for Osteoporosis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Zoledronic Acid
    Denmark

  • Study on the Use of Romosozumab and Zoledronic Acid for Treating Osteoporosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Zoledronic Acid
    • Romosozumab
    Denmark

  • Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoporosis
    • Osteoarthritis
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    Italy

  • Study on Dasatinib and Quercetin or Nicotinamide Riboside for Patients with Osteoporosis or Osteopenia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteopenia
    • Osteoporosis
    Investigated Drugs:
    • Dasatinib
    Denmark
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!